Literature DB >> 14961598

Synthesis, modeling, and anti-tubulin activity of a D-seco paclitaxel analogue.

Luciano Barboni1, Guido Giarlo, Massimo Ricciutelli, Roberto Ballini, Gunda I Georg, David G VanderVelde, Richard H Himes, Minmin Wang, Ami Lakdawala, James P Snyder.   

Abstract

[reaction: see text] We have previously described a model of paclitaxel-microtubule binding that led to the prediction that analogues of paclitaxel lacking any D ring could stabilize microtubules as well as paclitaxel if the substituent present at C4 did not have unfavorable steric interactions with the binding pocket. We report the synthesis of a 4-methyl paclitaxel analogue, compound 1, which bears this prediction out. Compound 1 is as potent as paclitaxel at microtubule stabilization in vitro; however, it has only about one-four-hundredth the cytotoxicity of paclitaxel.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14961598     DOI: 10.1021/ol036204c

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

Review 1.  Recent advances in the study of the bioactive conformation of taxol.

Authors:  Liang Sun; Carlos Simmerling; Iwao Ojima
Journal:  ChemMedChem       Date:  2009-05       Impact factor: 3.466

2.  The quest for a simple bioactive analog of paclitaxel as a potential anticancer agent.

Authors:  David G I Kingston; James P Snyder
Journal:  Acc Chem Res       Date:  2014-07-23       Impact factor: 22.384

Review 3.  Prodrug Strategies for Paclitaxel.

Authors:  Ziyuan Meng; Quanxia Lv; Jun Lu; Houzong Yao; Xiaoqing Lv; Feng Jiang; Aiping Lu; Ge Zhang
Journal:  Int J Mol Sci       Date:  2016-05-23       Impact factor: 5.923

4.  Synthesis, cytotoxic activity, and SAR analysis of the derivatives of taxchinin A and brevifoliol.

Authors:  Yu Zhao; Na Guo; Li-Guang Lou; Yu-Wen Cong; Li-Yan Peng; Qin-Shi Zhao
Journal:  Bioorg Med Chem       Date:  2008-03-20       Impact factor: 3.641

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.